Table 3.
Acute NEC (n=18) | Controls (n=30) | p Values* | |
---|---|---|---|
Total cells | 102 882 (56 028; 236 800)† | 179 489 (107 768; 262 712) | 0.30 |
Live CD3 | 3344 (1551; 6086) | 2800 (1448; 6525) | 1.00 |
CD3CD4 | 1438 (571; 4000) | 1242 (650; 3049) | 0.94 |
CD4CD45RO | 538 (182; 1190) | 906 (428; 2274) | 0.27 |
CD3CD8 | 559 (288; 1448) | 333 (172; 932) | 0.36 |
Naive Treg | 11 (6; 20) | 9 (3; 23) | 0.64 |
Treg‡ | 44 (18; 80) | 100 (33; 164) | 0.12 |
Live CD3 (%) | 2.3 (1.1; 5.5) | 1.9 (0.6; 4.2) | 0.42 |
CD4/CD3 (%) | 46.9 (40.9; 56.6) | 48.57 (39.7; 57.3) | 0.77 |
CD45RO/CD4 (%) | 46.2 (30.2; 64.6) | 65.5 (51.0; 82.3) | 0.01 |
CD8/CD3 (%) | 20.5 (11.3; 31.3) | 14.5 (10.0; 18.0) | 0.04 |
Naive Treg/CD4 (%) | 0.9 (0.6; 1.0) | 0.6 (0.2; 1.4) | 0.36 |
Treg/CD4 (%) | 2.9 (2.0; 4.6) | 6.6 (4.0; 11.8) | 0.001 |
Naive Treg/CD8 (%) | 1.5 (0.1; 3.2) | 1.2 (0.5; 4.9) | 0.62 |
Treg/CD8 (%) | 6.6 (4.5; 9.3) | 25.9 (11.0; 47.6) | <0.001 |
Wilcoxon rank sum test.
Median (first quartile; third quartile).
Treg defined as viable CD4 CD25high FOXP3high CD127low CD45RO cells.